KOSDAQ · Consumer Defensive · ₩531B
₩8,290-0.12%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 3.1% · as of 26.09.11
Among 36 신약 개발 peers
Quarterly Revenue Growth
“신약 개발은 한 걸음 나갔고 본업 회복이 관건이에요.”
In the company's words · 2026 2분기 filing